文献速递急性肾损伤慢性肾脏病

FSTL3缺失揭示激活素信号调控巨噬细胞L-精氨酸代谢与肾损伤的作用

Deletion of protein FSTL3 unravels the role of activin signaling in regulating macrophage L-arginine metabolism and kidney injury.
PubMed 文献 · Kidney Int · 2026-09-23

本研究探讨FSTL3在肾损伤中的作用。CKD或AKI患者血清FSTL3升高,且与eGFR负相关、与血肌酐正相关。小鼠Fstl3敲除减轻肾损伤和纤维化,与巨噬细胞SMAD3磷酸化及ARG1表达增加相关,激活素A与IL-4/IL-13协同增强巨噬细胞L-精氨酸代谢和多胺生成。

要点

  • CKD和AKI患者血清FSTL3水平升高,与肾功能指标相关。
  • 小鼠Fstl3敲除减轻肾损伤和纤维化,促进肾小管细胞增殖并减少凋亡。
  • 激活素A与IL-4/IL-13协同上调巨噬细胞Arg1等基因,增强L-精氨酸代谢。

核心结论

  • FSTL3缺失通过激活激活素-SMAD3-ARG1轴增强巨噬细胞L-精氨酸代谢,促进肾损伤修复。

研究设计与样本

  • 检测CKD或AKI患者血清FSTL3水平(ELISA)。
  • 采用叶酸或顺铂诱导小鼠肾损伤模型,并使用Fstl3敲除小鼠。
  • 从Smad3敲除小鼠分离骨髓来源巨噬细胞(BMDM),进行RNA-seq和LC-MS代谢分析。

主要发现

  • CKD或AKI患者血清FSTL3升高,CKD中与eGFR负相关、与血清肌酐正相关。
  • 小鼠Fstl3敲除减轻肾损伤和纤维化,伴随巨噬细胞SMAD3磷酸化和ARG1表达增加。
  • 损伤肾脏和经激活素A+IL-4处理的BMDM中精氨酸代谢通路富集。
  • 激活素A与IL-4/IL-13协同上调巨噬细胞Arg1、Slc7a2和Gatm表达,增强L-精氨酸代谢和多胺产生。
  • 叶酸处理后,Fstl3敲除小鼠肾小管细胞凋亡减少、增殖增加。

临床怎么用

  • 血清FSTL3可能作为CKD或AKI中反映肾功能损伤的生物标志物。
  • 靶向FSTL3-激活素信号通路或增强巨噬细胞L-精氨酸代谢可能促进肾损伤修复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Macrophages play a critical role in regulating kidney injury and repair. Arginase 1 (ARG1), a key enzyme in L-arginine metabolism, is predominantly expressed in macrophages in injured kidneys. Polyamines derived from L-arginine metabolism promote the resolution of tissue injury. Follistatin-like 3 (FSTL3) is a secreted protein that acts as an antagonist of activins. However, its role in the kidney remains unknown. METHODS: To study this, serum FSTL3 levels were measured in patients with chronic kidney disease (CKD) or acute kidney injury (AKI) using ELISA. Kidney injury was induced by folic acid or cisplatin in mice. Bone marrow-derived macrophages (BMDMs) were isolated from Smad3 knock out mice. Bulk RNA-seq analysis was performed on injured kidneys and BMDMs. L-arginine metabolites were analyzed with liquid chromatography-mass spectrometry. RESULTS: Serum FSTL3 levels were elevated in patients with CKD or AKI and were negatively correlated with estimated glomerular filtration rate and positively correlated with serum creatinine levels in CKD. Deletion of Fstl3 in mice ameliorated kidney injury and fibrosis, and this protective effect was associated with increased SMAD3 phosphorylation and ARG1 expression in macrophages. RNA-seq analysis revealed that arginine metabolism was highly enriched in the injured kidneys of Fstl3 knock out mice, as well as in BMDMs treated with activin A and IL-4. In vitro, activin A drastically synergized with the Th2 cytokines IL-4 and IL-13 to stimulate the expression of Arg1, along with Slc7a2 (also known as Cat2) and glycine amidinotransferase (Gatm), two other key genes involved in L-arginine metabolism, in macrophages, leading to enhanced L-arginine metabolism and polyamine production. Following folic acid treatment, Fstl3 knock out mice exhibited reduced tubular cell apoptosis and increased tubular cell proliferation. CONCLUSIONS: Our results uncover a previously unrecognized role for activin signaling in the regulation of L-arginine metabolism in macrophages. Fstl3 deletion activates this metabolism, thereby facilitating the resolution of kidney injury.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Xing F, Xiang L, Yan J, et al. Deletion of protein FSTL3 unravels the role of activin signaling in regulating macrophage L-arginine metabolism and kidney injury. Kidney Int. 2026. PMID: 42778149. doi:10.1016/j.kint.2026.08.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。